Research map: Enhancer-mediated DDIT4 activation by SMYD2-dependent H3K4me1 promotes pazopanib resistance in clear cell renal cell carcinoma

Back to the article

Papers in this map

  1. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome · Nathaniel D. Heintzman · 2007 · 3562 citations · Cited by this paper
  2. Sex- and menopause-related differences in immune and gastrointestinal symptom architecture in ME/CFS: evidence from factor analysis and structural equation modeling · 2026 · Related
  3. CUT&Tag for efficient epigenomic profiling of small samples and single cells · Hatice S Kaya-Okur · 2019 · 2341 citations · Cited by this paper
  4. Mechanisms and functions of the TRIM protein family in digestive system cancers · 2026 · Related
  5. Functional and Mechanistic Diversity of Distal Transcription Enhancers · Michael Bulger · 2011 · 856 citations · Cited by this paper
  6. Deep N-glycoproteomic profiling of FFPE tissues enables precise diagnosis of primary liver cancer from metastatic liver cancer · 2026 · Related
  7. Cancer statistics, 2026 · Rebecca L. Siegel · 2026 · 346 citations · Cited by this paper
  8. Canonical Wnt signaling in the regulation of prostate cancer stem cells: a key driver of castration-resistant prostate cancer and a therapeutic opportunity · 2026 · Related
  9. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update · Axel Bex · 2025 · 326 citations · Cited by this paper
  10. Decoding the cholangiocarcinoma tumor microenvironment: from single-cell and spatial atlases to translational therapeutic targeting · 2026 · Related
  11. Structural Basis of Substrate Methylation and Inhibition of SMYD2 · Andrew D. Ferguson · 2011 · 198 citations · Cited by this paper
  12. Methionine addiction in oral squamous cell carcinoma: a metabolic vulnerability targeted by engineered bacteria · 2026 · Related
  13. PRDM1/BLIMP1 induces cancer immune evasion by modulating the USP22-SPI1-PD-L1 axis in hepatocellular carcinoma cells · Qing Li · 2022 · 128 citations · Cited by this paper
  14. Targeting the IL-17C-M2 macrophage axis ameliorates fibrosis in endometriosis through MAPK/ERK signaling · 2026 · Related
  15. DDIT4 promotes gastric cancer proliferation and tumorigenesis through the p53 and MAPK pathways · Feng Du · 2018 · 109 citations · Cited by this paper
  16. Precision hyperbaric oxygen therapy: a biomarker-driven framework · 2026 · Related
  17. Baicalein upregulates DDIT4 expression which mediates mTOR inhibition and growth inhibition in cancer cells · Yujun Wang · 2014 · 97 citations · Cited by this paper
  18. Chemotherapy-driven gut microbiota remodeling in ovarian cancer: a prospective longitudinal study · 2026 · Related
  19. Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy · Qinghai Zeng · 2017 · 84 citations · Cited by this paper
  20. The physiological mTOR complex 1 inhibitor DDIT4 mediates therapy resistance in glioblastoma · Martha Foltyn‐Dumitru · 2019 · 82 citations · Cited by this paper
  21. Inhibition of SIRT1/2 upregulates HSPA5 acetylation and induces pro-survival autophagy via ATF4-DDIT4-mTORC1 axis in human lung cancer cells · Ning Mu · 2019 · 74 citations · Cited by this paper
  22. Inhibition of SMYD2 suppresses tumor progression by down-regulating microRNA-125b and attenuates multi-drug resistance in renal cell carcinoma · Libin Yan · 2019 · 74 citations · Cited by this paper
  23. Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma · Bin Chang · 2018 · 39 citations · Cited by this paper
  24. SMYD2 targets RIPK1 and restricts TNF-induced apoptosis and necroptosis to support colon tumor growth · Yuqiang Yu · 2022 · 36 citations · Cited by this paper
  25. Epigenetic regulation of SMAD3 by histone methyltransferase SMYD2 promotes lung cancer metastasis · Kwangho Kim · 2023 · 35 citations · Cited by this paper
  26. REDD1 expression in podocytes facilitates renal inflammation and pyroptosis in streptozotocin-induced diabetic nephropathy · Siddharth Sunilkumar · 2025 · 30 citations · Cited by this paper
  27. Enhancer transcription profiling reveals an enhancer RNA-driven ferroptosis and new therapeutic opportunities in prostate cancer · Sheng Ma · 2025 · 29 citations · Cited by this paper
  28. Histone H3K27 Trimethylation Modulates 5-Fluorouracil Resistance by Inhibiting PU.1 Binding to the DPYD Promoter · Rentian Wu · 2016 · 28 citations · Cited by this paper
  29. Targeting SMYD2 inhibits angiogenesis and increases the efficiency of apatinib by suppressing EGFL7 in colorectal cancer · Yi Zhang · 2022 · 23 citations · Cited by this paper
  30. Cytoskeleton remodeling induced by SMYD2 methyltransferase drives breast cancer metastasis · Alexandre G. Casanova · 2024 · 22 citations · Cited by this paper
  31. Enhancer-promoter hubs organize transcriptional networks promoting oncogenesis and drug resistance · Brent S. Perlman · 2024 · 20 citations · Cited by this paper
  32. Integrating radiomics and gene expression by mapping on the image with improved DeepInsight for clear cell renal cell carcinoma · Daisuke Kawahara · 2025 · 18 citations · Cited by this paper
  33. p53 promote oxidative stress, neuroinflammation and behavioral disorders via DDIT4-NF-κB signaling pathway · Kaiqi Zhang · 2025 · 17 citations · Cited by this paper
  34. Lysine methyltransferase SMYD2 enhances androgen receptor signaling to modulate CRPC cell resistance to enzalutamide · Junhong Li · 2024 · 16 citations · Cited by this paper
  35. Methylation of the chromatin modifier KMT2D by SMYD2 contributes to therapeutic response in hormone-dependent breast cancer · Ryan Blawski · 2024 · 14 citations · Cited by this paper
  36. Immune prognostic model for glioblastoma based on the ssGSEA enrichment score · Takanari Okamoto · 2025 · 14 citations · Cited by this paper
  37. The mechanism of lncRNA SSTR5-AS1 promoting ferroptosis resistance and immune escape in ovarian cancer cells by recruiting STAT3 to regulate SLC7A11 expression · Qiong Wei · 2025 · 9 citations · Cited by this paper
  38. A novel oncogenic enhancer of estrogen receptor-positive breast cancer · Chun‐Jie Bao · 2022 · 7 citations · Cited by this paper
  39. REDD1 is a gatekeeper of murine hematopoietic stem cell functions during stress responses · Vilma Barroca · 2022 · 5 citations · Cited by this paper

Source: OpenAlex (CC0)